Burosumab-twza Subcutaneous and Sinemet 250/25
Determining the interaction of Burosumab-twza Subcutaneous and Sinemet 250/25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Sinemet CR
- Burosumab-twza Subcutaneous-Sinemet CR 100/25
- Burosumab-twza Subcutaneous-Sinemet CR 200/50
- Burosumab-twza Subcutaneous-Sinequan
- Burosumab-twza Subcutaneous-Sinequan (Doxepin Capsules)
- Burosumab-twza Subcutaneous-Sinequan (Doxepin Oral Concentrate)
- Sinemet 250/25-Buspar
- Sinemet 250/25-Buspar Dividose
- Sinemet 250/25-Buspirone
- Sinemet 250/25-Buspirone Hydrochloride
- Sinemet 250/25-Busulfan
- Sinemet 250/25-Busulfan Concentrate Injection